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INHIBITORS OF PLANT PEPTIDE 
DEFORMYLASE FOR USE AS 
BROAD-SPECTRUM HERBICIDES AND 
METHODS FOR IDENTIFYING THE SAME 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application is a divisional of US. application Ser. No. 
09/617,805, ?led on Jul. 14, 2000. 
FIELD OF THE INVENTION 
The invention relates to a method of identifying herbicides 
and to the use of inhibitors of plant peptide deformylase as 
broad spectrum herbicides. 
BACKGROUND 
Ribosome-mediated synthesis of proteins begins With a 
methionine residue. In prokaryotes and eukaryotic organelles 
(mitochondria and chloroplasts), the methionyl moiety car 
ried by the initiator tRNA is N-formylated prior to its incor 
poration into a polypeptide (Meinnel and Blanquet, J. Bacte 
riol. 17517737-7740 (1993)). N-formylmethionine is 
therefore alWays incorporated at the N-terminus of a nascent 
polypeptide in prokaryotes (Adams, I. M. and Capecchi, M., 
Proc. Natl. Aca. Sci. U.S.A. 551147-155 (1966); Webster et 
al., Proc. Natl. Acad. Sci. U.S.A. 551155-161 (1966)). HoW 
ever, most mature proteins do not retain the N-formyl group 
(Marcker, K. and Sanger, F. J. Mol. Biol. 81835-840 (1964)). 
Instead, the N-formylmethionine group is removed post- or 
co-translationally in a process knoWn as deformylation, 
Which is catalyZed by peptide deformylase. 
Deformylation is catalyZed by peptide deformylase Which 
cleaves the formyl group from the nascent polypeptide chain 
(Adams, 1., J. Mol. Biol. 331571-589 (1968); Livingston, D. 
M. and Leder, P., Biochemistry 81435-443 (1969); Takeda, M. 
and Webster, R. E., Proc. Natl. Acad. Sci. U.S.A. 6011487 
1494 (1968)). 
Prior to the present invention, research in the area of pep 
tide deformylase activity and enZymology focused on the 
bacterial enzyme. For example, the structure of the core 
domain of E. coli peptide deformylase Was solved by NMR 
(Meinnel, T. et al., J. Mol. Biol. 2621375-386 (1996)) and the 
structure of the full-length protein by X-ray crystallography 
(Chan et al., Biochemistry 36113904-13909 (1997)). Becker 
et al., J. Biol. Chemistry 273(19): 11413-1 1416 (1998) solved 
the structure of the catalytically active E. coli enZyme in the 
nickel-bound form (PDF-Ni) and in inhibitor-complexed 
form. 
More recently, Ragusa et al., J. Mol. Biol. 2891 1445-1457 
(1999), investigated the substrate speci?city of Escherichia 
coli peptide deformylase by measuring the ef?ciency of the 
enZyme to cleave formylpeptides. Durand et al., Archives 
Biochemistry and Biophysics, 367(2)1297-302 (1999), tested 
a variety of peptide aldehydes and identi?ed calpeptin as a 
potent inhibitor of E. coli and B. sublilis peptide deformylase. 
The overall focus in the ?eld has been engineering site 
speci?c inhibitors of peptide deformylase With a goal of 
developing broad-spectrum antibiotics With loW to no mam 
malian toxicity. Rajagopalan et al., Biochemistry 36113910 
13918 (1997), identi?ed speci?c and potent inhibitors of the 
bacterial enZyme Which are potentially novel and neW anti 
biotic agents. Meinnel et al., Biochemistry 3814287-4295 
(1999) designed and synthesiZed substrate analogue inhibi 
tors of bacterial peptide deformylase and studied their capac 
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ity to undergo hydrolysis. To aid in the design of both the 
cobalt and Zinc containing E. coli peptide deformylase, Hao 
et al., Biochemistry 3814712-4719 (1999), studied the struc 
ture of the protein-inhibitor complexes of the cobalt and Zinc 
containing E. coli enzyme. 
Prior to the present invention, it Was generally accepted 
that peptide deformylase genes and proteins Were absent from 
eukaryotic cells. The present invention unexpectedly estab 
lishes, for the ?rst time, the existence of a peptide deformy 
lase gene and protein in eukaryotic cells, particularly in plant 
cells. The inventors have found that the deformylase is a novel 
and suitable target for identifying neW broad spectrum herbi 
cides. 
SUMMARY OF THE INVENTION 
In a ?rst aspect, the present invention relates to a plant 
peptide deformylase gene Which is expressed in a higher 
plant. A particularly preferred higher plant is Arabidopsis. 
More particularly preferred is the strainArabidopsis Zhaliana. 
In additional aspects, the present invention relates to a 
nucleotide and amino acid sequence encoding a plant peptide 
deformylase. 
In another aspect, the present invention relates to a recom 
binant vector comprising the peptide deformylase nucleotide 
sequence described above. 
In another aspect, the invention relates to a host cell that is 
transformed or transfected With the recombinant Vector of the 
invention. The host cell may be a prokaryo?c cell, such as a 
bacterial cell, or a eukaryotic cell, such as a plant cell or a 
mammalian cell. 
In yet another aspect, the present invention relates to an 
isolated or recombinantly expressed peptide deformylase 
polypeptide Which is encoded by a plant peptide deformylase 
gene as described above. 
In still another aspect, the present invention relates to a 
method for introducing the plant peptide deformylase gene 
into a cell Which does not express said gene, Which method 
comprises transforming a higher plant seed crop With the 
recombinant vector (vector containing a peptide deformylase 
gene) such that the cell expresses the peptide deformylase 
enZyme encoded by the gene. The cell may be a prokaryotic 
cell or a eukaryotic cell. 
In another aspect, the present invention provides a method 
of identifying an inhibitor of plant peptide deformylase, said 
method comprising: 
(a) incubating a catalytically effective amount of a plant 
peptide deformylase, With a suitable substrate, in the presence 
or absence of a candidate inhibitor compound, and 
(b) detecting and quantifying the enZyme product formed. 
The method may further comprises comparing the amount 
of enZyme product formed in the presence and absence of said 
candidate inhibitor. 
In a preferred embodiment, the method of the invention 
permits identi?cation of inhibitors of peptide deformylase 
derived from Arabidopsis Zhaliana. 
The invention also provides a method of identifying herbi 
cides Which comprises testing a compound in a peptide 
deformylase inhibition assay, and Where a measurable reduc 
tion of plant peptide deformylase is observed, subjecting the 
compound to an in vivo test for herbicidal activity. 
In another aspect, the invention relates to herbicides Which 
act by inhibiting plant peptide deformylase and Which are 
identi?ed by the methods of the invention. 
In another aspect, the invention provides a method of com 
bating Weeds comprising treating said Weeds With a herbi 
cide, Wherein said herbicide is a compound Which is an 
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inhibitor of peptide deformylase. A preferred herbicide is 
actinonin, Which is a potent inhibitor of plant peptide 
deformylase. 
The invention also provides a method of controlling veg 
etation comprising applying to plant foliage a herbicidally 
effective amount of an inhibitor of peptide deformylase. 
In a further aspect, the invention provides a method of 
inhibiting the activity of plant peptide deformylase compris 
ing exposing said peptide deformylase to an effective amount 
of an inhibitor of said peptide deformylase. 
Still further, the invention provides an antibody directed 
against peptide deformylase isolated from Arabidopsis 
Zhaliana. The antibody may be a polyclonal or a monoclonal 
antibody. 
In an additional aspect, the invention also provides a trans 
genic plant, Wherein said transgenic plant is engineered to be 
resistant to an inhibitor of plant peptide deformylase. 
In a further aspect, the invention provides a herbicidal 
composition comprising an inhibitor of plant peptide 
deformylase. In accordance With the present invention, the 
inhibitor is a herbicide, i.e. a compound having herbicidal 
activity. The composition of the invention may also contain a 
herbicidally acceptable surfactant. 
In yet another aspect, the present invention provides a 
method of controlling vegetation comprising applying to 
plant foliage a herbicidal composition, Wherein said herbi 
cidal composition comprises an inhibitor of plant peptide 
deformylase. Those of skill in the art Would recogniZe that the 
herbicide actinonin may be included in compositions of the 
present invention. 
Additional aspects of the invention Will be described 
throughout the speci?cation. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1A shoWs a CLUSTAL W (1.8) alignment ofArabi 
dopsis (truncated to the ChloroP predicted transit peptide) 
(SEQ ID NO.: 8) and E. coil peptide deformylase proteins 
(SEQ ID NO.: 7). 
FIG. 1B shoWs a CLUSTAL W (1.8) alignment ofArabi 
dopsis (truncated to the ChloroP predicted transit peptide) 
(SEQ ID NO.: 9) and Chlamydia peptide deformylase pro 
teins (SEQ ID NO.: 10). All three conserved proteins motifs 
found in prokaryotic sequences are present in theArabidopsis 
peptide deformylase (AtDEF 1). 
FIG. 2 is a gel shoWing an amplicon of the expected siZe, 
630 bp, Which Was created When Arabidopsis RNA Was 
reversed-transcribed and Atdefl ampli?ed With gene speci?c 
primers (RLH 146X147). 
FIG. 3 shoWs the results of in vitro import of Arabidopsis 
Zhaliana deformylase (AtDEFl) protein into isolated pea 
chloroplasts under standard, in vitro import conditions and 
processing to a mature form once inside the plastid. The 5.5 
kD shift from predicted precursor (28.9 kD) to processed 
(23.4 kD) forms Was observed after 15 and 30 minutes after 
initiation of the assay. Only the processed protein Was present 
after thermolysin treatment of the chloroplasts after 30 min 
utes of import. 
FIG. 4 shoWs detection of an expected siZe protein from 
~100 ug Arabidopsis total protein extract (soluble, lane 2; 
insoluble, lane 3) by AtDEFl antibody (Rabbit 95728) at 
l:50,000. Inclusion bodies (50 ng) used as antigen in making 
the antibody Were included in the standard lane. (lane 1). 
FIG. 5 shoWs ten-day old pea plants 48 hours after appli 
cation of actinonin (2.5 mg/ml) in 0.1% Tween-20 (left) or 
treated With 0.1% Tween-20 alone (right). 
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FIG. 6 is a 1% agarose gel in TBE buffer containing 0.1 
ug/ml ethidium bromide and subjected to electrophoresis. 
Amplicons of Reverse Transcriptase-Polymerase Chain 
Reactions (RT-PCR) reactions of Atdef2 are depicted. 
FIG. 7 is a 15% SDS-PAGE shoWing AtDEF2 after puri? 
cation. 
FIG. 8 shoWs spectrophotometric detection and quantita 
tion of p-nitroaniline released from formyl-Met-Leu-p-ni 
troanilide substrate folloWing sequential action of AtDEF2 
and Aeromonas proleolylica aminopeptidase. 
DETAILED DESCRIPTION OF THE INVENTION 
As discussed above, the present inventors have found that 
plant cells contain a peptide deformylase gene and protein, 
and the deformylase provides a novel and suitable target for 
identifying neW broad spectrum herbicides. The identi?ca 
tion of this neW target has Widespread implications in the 
agricultural area. Methods of identifying inhibitors of this 
target Will be useful for identifying neW broad spectrum her 
bicides, Which Will be used to control the groWth of Weeds. 
Chemical Weed control using herbicides is a poWerful tool in 
the modern technological age. In fact, it has become almost a 
universal practice to use herbicides to control groWth of unde 
sirable vegetation such as Weeds or plants. 
A particularly useful type of herbicide is one having a 
broad spectrum of herbicidal activity. The use of broad spec 
trum herbicides offers the advantage of obviating the need for 
multiple herbicides. Since some Weeds are resistant to herbi 
cides, clearly there is a need for the identi?cation of neW 
targets of inhibition and for identi?cation and production of 
effective herbicides that inhibit such targets. 
The present invention is based, at least in part, on the 
discovery of a plant nuclear gene that encodes a chloroplast 
targeted peptide deformylase polypeptide. Utilizing 
sequence data obtained from the Arabidopsis genome 
sequencing project (Accession Number AC 007591), the 
present inventors have isolated a cDNA from Arabidopsis 
Zhaliana that encodes peptide deformylase. The gene has 
substantial homology to bacterial peptide deformylase. The 
deduced translation of this DNA sequence revealed the pres 
ence of all three conserved protein motifs associated With 
prokaryotic peptide deformylase. (See FIG. 1B for sequence 
alignment.) 
Thus, the present invention provides a plant peptide 
deformylase gene Which is expressed in higher plants. A 
particularly preferred higher plant is Arabidopsis. More par 
ticularly preferred is the strain Arabidopsis Zhaliana. 
The invention also provides polynucleotide sequences 
Which encode a plant peptide deformylase. In particular, the 
invention encompasses the polynucleotide sequences of 
Atdefl and Atdef2 genes. Also Within the scope of the inven 
tion are polynucleotide sequences encoding a plant peptide 
deformylase Which have substantial identity to the polynucle 
otide sequence of Atdef1 or Atdef2. Such polynucleotide 
sequences are readily identi?able by those skilled in the art 
using techniques knoWn in the art such as site-speci?c 
mutagenesis and hybridization technology, such as hybrid 
iZation under stringent conditions. 
The invention further provides an isolated and puri?ed 
polynucleotide sequence Which hybridiZes under stringent 
conditions to the polynucleotide encoding the polypeptide 
comprising the amino acid sequence of AtDEFl or AtDEF2 
or a fragment thereof, as Well as an isolated and puri?ed 
polynucleotide Which is complementary to the polynucle 
otide encoding the polypeptide comprising the amino acid 
sequence of AtDEFl or AtDEF2 or a fragment thereof. 
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The invention also provides an isolated and puri?ed poly 
nucleotide sequence comprising the polynucleotide sequence 
of Atdefl or a fragment thereof, and an isolated and puri?ed 
polynucleotide variant having at least 70% polynucleotide 
sequence identity to the polynucleotide comprising the poly 
nucleotide sequence of Atdefl or Atdef2 or a fragment 
thereof. The invention also provides an isolated and puri?ed 
polynucleotide having a sequence complementary to the 
polynucleotide comprising the polynucleotide sequence of 
Atdefl or Atdef2 or a fragment thereof. 
Amino acid sequences encoding a plant peptide deformy 
lase are also Within the purvieW of the present invention. Such 
amino acids sequences include but are not limited to the 
amino acid sequences of AtDEFl and AtDEF2. 
Additionally, and of equal importance, the inventors have 
identi?ed a putative N-terminal targeting sequence for chlo 
roplasts. (FIGS. 1a and 1b) Thus, perhaps as a remnant of its 
prokaryotic origins, the chloroplast has retained N-formyl 
methionine as its initiator of protein translation. 
The present invention is based on a novel herbicidal mode 
of action, i.e., inhibition of plant peptide deformylase. Dis 
covery of this novel mode of action opens up the opportunity 
for identifying novel chemicals that inhibit the enZyme target 
either directly or folloWing metabolism to an active inhibitor 
in plants (“indirect inhibitors”). 
Because all non-parasitic plants contain chloroplasts, and 
deletion and/or mutation of peptide deformylase in prokary 
otic organisms is lethal, it is expected that inhibition of pep 
tide deformylase activity in the chloroplast Will be lethal to 
plants. 
Thus, the invention relates to the identi?cation of com 
pounds, as Well as the development of neW compounds 
capable of acting as highly speci?c inhibitors of chloroplastic 
peptide deformylase, for use as broad spectrum herbicides. 
The invention provides a method of identifying potential 
herbicides Which comprises testing a candidate in a peptide 
deformylase assay for direct and indirect inhibitors. Indirect 
inhibitors are those inhibitors that require conversion in 
plants. 
More speci?cally, the invention relates to a method of 
identifying an inhibitor of plant peptide deformylase, said 
method comprising: 
(a) incubating an effective amount of a plant peptide 
deformylase, With a suitable substrate, in the presence or 
absence of a candidate inhibitor compound; and 
(b) detecting and quantifying the enZyme product formed. 
The method may further comprise comparing the amount 
of enZyme product formed in the presence and absence of said 
candidate inhibitor. 
The invention permits identi?cation of inhibitors of pep 
tide deformylase derived from Arabidopsis Zhaliana as Well 
as inhibitors of peptide deformylase derived from otherplants 
including, but not limited to, soybean, sun?ower, cotton, 
corn, tobacco, alfalfa, Wheat, barley, oats, sorghum, hard 
Wood and softWood trees, forage grasses, pea, canola, ?ax, 
tomato, sugar beet, potato, rice, lettuce and radish. 
The invention employs an isolated or recombinantly 
expressed plant peptide deformylase polypeptide encoded by 
a plant peptide deformylase gene. The invention also encom 
passes variants of this polypeptide, and particularly those 
Which retain peptide deformylase activity. 
A cDNA for a peptide deformylase, such as anArabidopsis 
peptide deformylase cDNA, may be engineered and inserted 
into bacterial expression vectors to verify functional activity, 
subcellular localiZation, and to generate a suitable amount of 
the protein for crystallization attempts and acquisition of 
antibodies. 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
6 
Production of a recombinant plant peptide deformylase 
polypeptide may be achieved by a method comprising: 
(a) transforming a suitable host cell With a vector compris 
ing a gene encoding a plant peptide deformylase polypeptide, 
the gene being operably linked to suitable regulatory 
sequences; 
(b) groWing the transformed cell under conditions Where 
the peptide deformylase is expressed. 
To obtain a peptide deformylase polypeptide, recombinant 
host cells expressing the peptide deformylase polypeptide 
may be groWn in a conventional manner in a suitable culture 
medium and then lysed using conventional means such as 
enZymatic degradation or detergents or the like. The 
expressed protein may be isolated as an insoluble inclusion 
body. Alternatively, the protein can be separated and puri?ed 
by standard chromatography techniques. 
Transformation of a nucleic acid molecule into a cell can be 
accomplished by any method by Which a nucleic acid mol 
ecule can be inserted into the cell. Transformation techniques 
include, but are not limited to, transfection, electroporation, 
microinj ection, lipofection, adsorption, and protoplast 
fusion. 
Suitable host cells are knoWn to those of skill in the art and 
include, but are not limited to bacterial cells such as BL21 
(DE3)pLysS, BL21(DE3), and GI724. Those of skill in the art 
Would recogniZe that the host cell encompassed by the present 
invention may be a prokaryotic cell, such as a bacterial cell, or 
a eukaryotic cell, such as a plant cell or a mammalian cell. 
Suitable expression vectors are knoWn and routinely used 
in the art and may include, but are not limited to, pLEX and 
pET. 
One type of recombinant vector, referred to herein as a 
recombinant molecule, comprises a nucleic acid molecule of 
the present invention operatively linked to an expression vec 
tor. The phrase operatively linked refers to insertion of a 
nucleic acid molecule into an expression vector in a manner 
such that the molecule is able to be expressed When trans 
formed into a host cell. As used herein, an expression vector 
is a DNA or RNA vector that is capable of transforming a host 
cell and of effecting expression of a speci?ed nucleic acid 
molecule. Preferably, the expression vector is also capable of 
replicating Within the host cell. Expression vectors can be 
either prokaryotic or eukaryotic, and are typically viruses or 
plasmids. Expression vectors of the present invention include 
any vectors that function (i.e., direct gene expression) in 
recombinant cells of the present invention, including in bac 
terial, fungal, endoparasite, insect, other animal, and plant 
cells. Preferred expression vectors of the present invention 
can direct gene expression in bacterial, yeast, insect and 
mammalian cells and more preferably in the cell types dis 
closed herein. 
In particular, expression vectors of the present invention 
contain regulatory sequences such as transcription control 
sequences, translation control sequences, origins of replica 
tion, and other regulatory sequences that are compatible With 
the recombinant cell and that control the expression of nucleic 
acid molecules of the present invention. In particular, recom 
binant molecules of the present invention include transcrip 
tion control sequences. Transcription control sequences are 
sequences Which control the initiation, elongation, and termi 
nation of transcription. Particularly important transcription 
control sequences are those Which control transcription ini 
tiation, such as promoter, enhancer, operator and repressor 
sequences. Suitable transcription control sequences include 
any transcription control sequence that can function in at least 
one of the recombinant cells of the present invention. A vari 
ety of such transcription control sequences are knoWn to those 
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skilled in the art. Preferred transcription control sequences 
include those Which function in bacterial, yeast, insect and 
mammalian cells, such as, tac, lac, trp, trc, oxy-pro, omp/lpp, 
rmB, bacteriophage lambda (such as lambda PL and lambda 
PR and fusions that include such promoters), bacteriophage 
T7, T7lac, bacteriophage T3, bacteriophage SP6, bacterioph 
age SP01, metallothionein, alpha-mating factor, Pichia alco 
hol oxidase, alphavirus subgenomic promoters (such as Sind 
bis virus subgenomic promoters), antibiotic resistance gene, 
baculovirus, Heliolhis Zea insect virus, vaccinia virus, herp 
esvirus, raccoon poxvirus, other poxvirus, adenovirus, 
cytomegalovirus (such as intermediate early promoters), sim 
ian virus 40, retrovirus, actin, retroviral long terminal repeat, 
Rous sarcoma virus, heat shock, phosphate and nitrate tran 
scription control sequences as Well as other sequences 
capable of controlling gene expression in prokaryotic or 
eukaryotic cells. Additional suitable transcription control 
sequences include tissue-speci?c promoters and enhancers as 
Well as lymphokine-inducible promoters (e.g., promoters 
inducible by interferons or interleukins). 
Puri?ed peptide deformylase is highly active toWard 
N-formylated peptide substrates, thus rendering these pep 
tides suitable for use in the methods of the present invention. 
Suitable substrates include, but are not limited to formylated 
dipeptides and formyl-Met-Leu-p-nitroanilide as described 
by Wei and Pei, Analytical Biochemistry 250:29-34 (1997) 
and other formylated peptides as described by Raj agopalan et 
al., Biochemistry 36:13910-13918 (1997). 
Peptide deformylase activity may be assessed by detecting 
and quantifying the amount of enzyme product formed in the 
method of the invention. Speci?cally, peptide deformylase 
activity can be quanti?ed by measuring the amount of 
released p-nitroaniline (end product) from formyl-Met-Leu 
p-nitroanilide using a coupled enzyme assay WithAeronomo 
nasproleolylica aminopeptidase. This permits assessment of 
the catalytic properties of peptide deformylase using a series 
of synthetic N-formylated peptides as substrates in a continu 
ous spectrophotometric assay. (Wei and Pei, Analytical Bio 
chemistry 250:29-34 (1997)). A continuous spectrophoto 
metric assay may be used to monitor plant peptide 
deformylase activity, i.e., to detect and quantify the enzyme 
product formed in the method of the invention. Alternatively, 
a discontinuous spectrophotometric assay may also be used. 
The presence of peptide deformylase protein may be 
assessed using immunological methods, such as by using 
antibody directed to the protein or a part thereof, and by 
knoWn enzymatic assays, such as peptide deformylase activ 
ity assays as described above. Coupled deformylase assays 
may also be used for measuring enzymatic activity and inhi 
bition thereof as described by Rajagopalan et al., Biochem 
istry 36: 13910-13918 (1997). 
The invention also relates to a method of inhibiting the 
activity of plant peptide deformylase comprising exposing 
said peptide deformylase to an effective amount of an inhibi 
tor of said peptide deformylase. An effective amount of an 
inhibitor is the concentration of the inhibitor that is required 
to reduce plant peptide deformylase activity. 
The invention also relates to a method of identifying her 
bicides Which comprises testing a candidate inhibitor in a 
peptide deformylase assay, and Where a measurable reduction 
of plant peptide deformylase is observed, subjecting the can 
didate inhibitor to conventional test(s) to con?rm the in vivo 
herbicidal activity. 
A measurable reduction includes a reduction that is statis 
tically signi?cant, statistically signi?cant being de?ned as the 
results from analysis of variance Where the F-ratio, LSD 
(least signi?cant difference), orthogonal/non-orthogonal 
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comparison, or any other statistical technique for mean sepa 
ration, that indicates the means are different at 0.05 or 0.01 
level. In one embodiment of the invention, the measurable 
reduction is at least 10%. 
Conventional tests for con?rming in vivo herbicidal activ 
ity include, but are not limited to, detecting decreases in fresh 
Weight, dry Weight, chlorophyll, protein, and germination. 
Typical symptoms resulting from treatment of plant foliage 
With herbicides are cessation of groWth folloWed by chlorosis 
and necrosis. 
Although in vitro peptide deformylase assays Will identify 
intrinsic herbicidal activity, it may in some cases be necessary 
to use conventional tests to con?rm the in vivo herbicidal 
activity. Accordingly, the invention further relates to a method 
of identifying potential herbicides that can be metabolized to 
an inhibitor of peptide deformylase in plants Which comprises 
testing a compound in a peptide deformylase assay, and 
Where a measurable reduction of plant peptide deformylase is 
observed, subjecting the compound to conventional test(s) to 
con?rm the in vivo herbicidal activity. 
Of course, those skilled in the art Would appreciate that the 
invention encompasses herbicides identi?ed by the methods 
of the invention. The invention also includes the use as a 
herbicide of a compound Which is an inhibitor of plant peptide 
deformylase, With the proviso that the compound is not a 
general enzyme inhibitor. 
Still further, the invention relates to a method of combating 
Weeds comprising treating said Weeds With a herbicide, 
Wherein said herbicide is a compound Which is an inhibitor of 
peptide deformylase in plants. 
The invention also relates to a method of controlling veg 
etation comprising applying to plant foliage a herbicidally 
effective amount of an inhibitor of peptide deformylase. 
Since bacterial peptide deformylase is a metallo hydrolase, 
compounds containing a metal ion chelating group are poten 
tial inhibitors of the enzyme. These compounds may also 
inhibit plant peptide deformylase and are encompassed With 
the scope of the present invention. 
Examples of inhibitors of the invention include, but are not 
limited to, divalent metal chelators, dithiol compounds such 
as 1,2-ethanedithiol, 1,3-propanedithiol, 2,3-dimercapto-1 
propanol, 2,3-dimercapto-1-propanol, 2,3-dimercapto-1 
propanesulfonic acid and 1,5-pentanedithiol. 
Also included are divalent metal-chelating agents such as 
1,10-phenanthroline, 2-mercapto ethanol, glutathione, 
EDTA, thiophenol and thio-speci?c agents [p-(chloro mer 
curi)-benzoate] and iodoacetate. 
Also included are 7,8 benzoquinoline, methyl 2-(sulfanyl 
methyl) hexanoate (TN) and imino[(5-methoxy-5-oxo-4-[2 
sulfanylmethyl)-hexanoyl] amino pentyl)amino] methamine 
(TNR). 
The inhibitors of the invention may be substrate analogue 
inhibitors such as thiophan (3-mercapto-2-benzylpro 
panoylglycine) and captopril (3-mercapto-2-methylpro 
panoyl proline), or other types of enzyme inhibitors knoWn in 
the art. Such inhibitors may be designed and/or synthesized 
using methods knoWn in the art, including transition-state 
analogue chemistry, such as used by Pei et al. (Dept. of 
Chemistry, The Ohio State University, Columbus, Ohio). 
Also included as inhibitors of the invention are peptide 
aldehydes, including those described by Durand et al., 
Archives Biochemistry and Biophysics, 367(2):297-302 
(1999), as inhibitors of bacterial peptide deformylase. 
Given the absence of a protein crystal structure for plant 
peptide deformylase, Which has a speci?c and unique amino 
US 7,419,815 B2 
9 
acid sequence different from any previously described pep 
tide deformylase, inhibitors of the invention may also include 
novel compounds. 
Those of skill in the art Would recognize that the inhibitors 
of the invention may be used as non-selective herbicides. 
The importance of peptide deformylase to the Well being of 
plants has been demonstrated by the potent herbicidal effects 
obtained When the enZyme is inhibited. Recent studies have 
shoWn the fungal product, actinonin, to be an inhibitor of 
bacterial peptide deformylase (Chen et al., Biochemistry, 
39(6):1256-1263 (2000). A role for peptide deformylase in 
plant groWth Was suggested from analysis of the effects of the 
application of actinonin, on the groWth of pea plants. 
As shoWn in FIG. 5 and Example 5, observable alterations 
in plant groWth, i.e., stunting and yelloWing of pea plants, 
Were evident in the presence of actinonin. Nearly complete 
inhibition of peptide deformylase activity Was observed in an 
in vitro peptide deformylase inhibition assay. (FIG. 8 and 
Example 8) This data establishes that the potent herbicidal 
activity of actinonin is due to inhibition of peptide deformy 
lase. This mode of action has not previously been described 
for herbicides. 
Herbicidal Compositions 
The inhibitors of the invention may be formulated as her 
bicidal compositions. A herbicidal composition can be for 
mulated in a conventional manner using an inhibitor of plant 
peptide deformylase polypeptide, as an active ingredient, 
together With suitable carriers, diluents, emulsi?ers and/or 
dispersants. The herbicidal composition can be formulated as 
a Wettable poWder, pellets, granules or dust or as a liquid 
formulation With aqueous or non-aqueous solvents as a foam, 
gel, suspension, or concentrate. 
A method for controlling the groWth of Weeds in accor 
dance With this invention can comprise applying (e. g., spray 
ing), to a locus (area) to be protected, an herbicidally effective 
amount of an inhibitor of plant peptide deformylase poly 
nucleotide and/or polypeptide of the invention. The locus to 
be protected can include, for example, the habitat of the 
groWing vegetation or an area Where vegetation is to be 
groWn. 
It Will be appreciated that to effect control of undesired 
plant vegetation pursuant to this invention, recourse may be 
had to herbicidal activity Whereby undesired vegetation is 
killed and/or to plant groWth regulant activity Whereby the 
further groWth of the vegetation is stunted, inhibited and/or 
sloWed Without actually killing all of the undesired vegetation 
treated With the composition. 
The herbicidal and groWth regulating compositions of the 
invention include aqueous concentrates Which can be shipped 
and stored until diluted With more Water on site to produce the 
?nal solution for application to the foliage as by spraying. 
LikeWise the herbicidal and the plant groWth regulant com 
positions of this invention include the more dilute aqueous 
solutions for use in application to the foliage. These more 
dilute aqueous solutions are preferably formed simply by 
suitably diluting a concentrate of this invention With Water (if 
a poWder or granular concentrate) or With more Water (if a 
liquid concentrate) to achieve the appropriate dosage, but 
alternatively, can be formed on site by mixing the ingredients 
separately and/ or in sub-combinations With suf?cient Water 
on site to achieve the appropriate dosage. Use of the solid or 
liquid concentrates of this invention is preferable as it is a 
much simpler operation and minimiZes the possibility of 
blending errors. Moreover, if desired, other components can 
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be introduced into the ?nal solution at the time the concen 
trate is blended With Water to form the diluted solution for 
application to the foliage. 
The herbicides of the invention may be applied With a 
surfactant in order to improve leaf Wetting and assist in pen 
etration of the active ingredient into the leaf. The surfactant is 
typically an inert ingredient in the formulation. Surfactants of 
virtually any class may be used. Examples of surfactants 
Which may be useful include StilWet, TWeen, polyalkylene 
glycols (such as polyethylene glycols), alkanolamides, 
betaine derivatives, ethoxylated propoxylated block copoly 
mers, glycerol esters, glycol esters, imidaZolines and imida 
Zoline derivatives, lanolin derivatives, lecithin derivatives, 
tertiary or quaternary polyoxyalkylene alkylamines, poly 
oxyalkylene and nonpolyoxyalkylene alkylamine oxides, 
polyoxyalkylene alkylethers, polyoxyalkylene alky 
larylethers, polyoxyalkylene alkylesters, alkoxylated and 
non-alkoxylated sorbitan esters, alkyl glycosides, alkyl 
polyglycosides, sucrose esters, sucrose glycerides, alkyl sul 
fates or phosphates, ole?n sulfonates, alkylaryl sulfonates, 
polyoxyalkylene alkylether sulfates or phosphates, sulfosuc 
cinate derivatives, sulfosuccinamates, taurates, sulfates and 
sulfonates of oils, fatty acids, alcohols, alkoxylated alcohols, 
fatty esters and aromatic derivatives, mixtures thereof and the 
like. The surfactant is preferably StilWet. Those skilled in the 
art Will recogniZe that other surfactants not included above 
may also useful. 
Effective concentrations of the herbicides and herbicidal 
compositions and formulations of the invention may be 
readily determined using the methods described herein 
Wherein preparations are bioassayed for their inhibitory abil 
ity to knoWn preparations of peptide deformylase. In order to 
control groWth of vegetation, the compositions should con 
tain the amount of inhibitor required to effectuate plant 
groWth regulant activity Whereby the further groWth of the 
vegetation is stunted, inhibited and/or sloWed Without actu 
ally killing all of the undesired vegetation treated With the 
composition. 
Antagonists 
Peptide deformylase polypeptides of the invention may be 
used to assess the binding of small molecule substrates and 
ligands in, for example, cells, cell-free preparations, chemical 
libraries, and natural product mixtures. These substrates and 
ligands may be natural substrates and ligands or may be 
structural or functional mimetics. See, e.g., Coligan et al., 
Current Protocols in Immunology 1(2): Chapter 5 (1991). 
Accordingly, the invention provides a method of screening 
compounds to identify those Which block (antagonist) the 
action of peptide deformylase polypeptides. The method of 
screening may involve high-throughput techniques. For 
example, to screen for antagonists, a synthetic reaction mix, a 
cellular compartment, such as a membrane, cell envelope or 
cell Wall, or a preparation of any thereof, comprising a peptide 
deformylase polypeptide and a labeled substrate or ligand of 
such polypeptide is incubated in the absence or the presence 
of a candidate molecule that may be a peptide deformylase 
antagonist. The ability of the candidate molecule to antago 
niZe the peptide deformylase polypeptide is re?ected in 
decreased binding of the labeled ligand or decreased produc 
tion of product from such substrate. Molecules that bind 
gratuitously, i.e., Without inducing the effects of a peptide 
deformylase polypeptide are most likely to be good antago 
nists. Detection of the rate or level of production of product 
from substrate may be enhanced by using a reporter system. 
Reporter systems that may be useful in this regard include but 
are not limited to calorimetric labeled substrate converted 
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into product, a reporter gene that is responsive to changes in 
peptide deformylase polynucleotide or polypeptide activity, 
and binding assays knoWn in the art. 
Another example of an assay for peptide deformylase 
antagonists is a competitive assay that combines peptide 
deformylase and a potential antagonist With peptide deforrny 
lase-binding molecules, recombinant peptide deformylase 
binding molecules, natural substrates or ligands, or substrate 
or ligand mimetics, under appropriate conditions for a com 
petitive inhibition assay. Peptide deformylase can be labeled, 
such as by radioactivity or a colorimetric compound, such 
that the number of peptide deformylase molecules bound to a 
binding molecule or converted to product can be determined 
accurately to assess the effectiveness of the potential antago 
nist. 
Potential antagonists include small organic molecules, 
peptides, polypeptides and antibodies that bind to a poly 
nucleotide or polypeptide of the invention and thereby inhibit 
or extinguish its activity. Potential antagonists also may be 
small organic molecules, a peptide, a polypeptide such as a 
closely related protein or antibody that binds the same sites on 
a binding molecule, such as a binding molecule, Without 
inducing peptide deformylase-induced activities, thereby 
preventing the action of peptide deformylase by excluding 
deformylase from binding. 
Potential antagonists also include a small molecule that 
binds to and occupies the binding site of the polypeptide 
thereby preventing binding to cellular binding molecules, 
such that normal biological activity is prevented. Examples of 
small molecules include but are not limited to small organic 
molecules, peptides or peptide-like molecules. Other poten 
tial antagonists include antisense molecules (see Okano, J. 
Neurochem. 56:560 (1991); Oligodeoxynucleotides as Anti 
sense Inhibitors of Gene Expression, CRC Press, Boca Raton, 
Fla. (1988), for a description of these molecules). Preferred 
potential antagonists include compounds related to and vari 
ants of peptide deformylase. 
Antibodies 
The present invention further relates to an antibody 
directed against plant peptide deformylase. In this regard, the 
polypeptides of the invention or variants thereof, or cells 
expressing them can be used as an antigen to produce anti 
bodies immunospeci?c for such polypeptides. “Antibodies” 
as used herein includes monoclonal and polyclonal antibod 
ies, chimeric, single chain, simianiZed antibodies and human 
iZed antibodies, as Well as Fab fragments, including the prod 
ucts of an Fab immunoglobulin expression library. 
Antibodies generated against the polypeptides of the 
invention can be obtained by administering the polypeptides 
or epitope-bearing fragments, analogues or cells to an animal 
using routine protocols. For preparation of monoclonal anti 
bodies, any technique knoWn in the art that provides antibod 
ies produced by continuous cell line cultures can be used. 
Examples include various techniques, such as those in 
Kohler, G. and Milstein, C., Nature 256:495-497 (1975); 
KoZbor et al., Immunology Today 4:72 (1983); Cole et al., 
Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, 
Inc., pg. 77-96 (1985). 
Techniques for the production of single chain antibodies 
(US. Pat. No. 4,946,778) can be adapted to produce single 
chain antibodies to polypeptides of this invention. 
Alternatively phage display technology may be utiliZed to 
select antibody genes With binding activities toWards the 
polypeptide either from repertoires of PCR ampli?ed v-genes 
of lymphocytes from humans screened for possessing anti 
def or from naive libraries (McCafferty, J. et al., Nature 348: 
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552-554 (1990); Marks, J. et al., Biotechnology 10:779-783 
(1992)). The a?inity of these antibodies can also be improved 
by chain shuf?ing (Clackson, T. et al., Nature 352:624-628 
(1 991)). 
If tWo antigen binding domains are present each domain 
may be directed against a different epitopeitermed ‘bispe 
ci?c’ antibodies. 
The above-described antibodies may be employed to iso 
late or to identify clones expressing plant peptide deformy 
lase polypeptides and to purify the polypeptides by a?inity 
chromatography. 
Transgenics 
As With other broad spectrum herbicides, such as glypho 
sate, overexpression or expression of altered forms of peptide 
deformylase in plants using conventional transformation 
techniques might generate plants resistant to the adverse 
effects of peptide deformylase inhibitors. 
Thus, the invention further relates to a transgenic plant, 
Wherein said plant is engineered to be resistant to inhibitors of 
plant peptide deformylase. In a further aspect, the present 
invention relates to a recombinant or transgenic plant trans 
formed With a peptide deformylase gene such that the 
deformylase is over expressed. 
Additionally, sense and antisense forms of the Arabidop 
sis, as Well as bacterial peptide deformylases, may be engi 
neered into plant transformation vectors for the construction 
of transgenic plants With up- and doWn-regulated levels of 
peptide deformylase, for testing as resistant and susceptible 
plant species to peptide deformylase inhibitors. 
A variety of techniques may be used to introduce foreign 
genes into plant cells. One common method used to introduce 
foreign genes into plant cells is transformation With disarmed 
Agrobaclerium, a relatively benign natural plant pathogen. 
A grobaclerium actively mediates transformation eventsithe 
integration of a gene providing a desired phenotypic traitias 
part of the natural process it utiliZes When it infects a plant 
cell. Methods for transferring foreign genes into plant cells 
and the subsequent expression of the inserted genes in plants 
regenerated from transformed cells are Well knoWn in the art. 
(See, e.g., De Block et al., The EMBO Journal 3: 1681 (1984); 
Horsch et al. Science 227:1229 (1985); and C. L. Kado (Crit. 
Rev. Plant. Sci. 10:1 (1991)). 
The technique knoWn as microproj ectile bombardment has 
been successfully used to introduce genes encoding neW 
genetic traits into a number of crop plants, including cotton, 
maiZe, tobacco, sun?owers, soybeans and certain vegetables. 
(See for example, US. Pat. No. 4,945,050, issued to Sanford; 
Sanford et al., Trends in Biotechnology 6:299 (1988); San 
ford et al., Part. Sci. Technol. 5:27 (1988); J. J. Finer and M. 
D. McMullen, Plant Cell Reports 8:586-589 (1990); and Gor 
don-Kamm, The Plant Cell 2:603 (1990)). 
Organogenesis, the development of plantlets from speci?c 
plant structures such as leaf disks or root tips, has been used 
to regenerate plants folloWing transformation. An alternative 
approach has been described by Feldman, Who has shoWn that 
it is feasible to vacuum in?ltrate the ?oral meristems of small 
plants, or in the case of Arabidopsis, the entire plant With 
A grobacleriumand obtain transgenic progeny. See K. A. Feld 
man et al., “A grobaclerium -Mediated Transformation of Ger 
minating Seeds of Arabidopsis Zhaliana: A Non-Tissue Cul 
ture Approach,” Mol. Gen. Genet. 308:1-9 (1987). 
The use of speci?c herbicides relies on differential uptake 
and/or metabolism betWeen Weed and crop plant or on appli 
cation of the herbicide before planting in a ?eld. Herbicide 
tolerant plants/ crops can be created by either of three strate 
gies: i) increasing the level of the target enZyme for the 
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herbicide (See, eg US. Pat. No. 4,940,835, issued to Shah et 
al.), ii) expressing a mutant enzyme that is not affected by the 
compound (Comai, L., et al., Nature 3171741-744 (1985)), iii) 
expressing an enzyme that detoxi?es the herbicide (De Block, 
M., et al., EMBO J. 612513-2518 (1987), Stalker, D. M., et al., 
Science 2421419-423 (1988)), or iv) knocking out or anti 
sense doWn regulation of the plant formyl transferase gene. 
With the ?rst approach, i), a cDNA encoding plant peptide 
deformylase may be transferred into a plant in order to over 
express the deformylase enZyme. Over expression of the 
enZyme alloWs the transgenic plants to groW in the presence 
of higher levels of the herbicide that kills the Wild-type or 
non-transgenic plants. 
With approach ii), herbicide-tolerant plants are created by 
use of mutant forms of the plant or bacterial peptide deforrny 
lase that are less sensitive to inhibition by the herbicide. 
Genes encoding these mutants may be cloned and expressed 
in plants. The transgenic plants should exhibit tolerance to 
levels of herbicide that kill Wild-type plants. 
Plant peptide deformylase is synthesiZed in the cytoplasm 
and translocated to the chloroplast by proteins that recogniZe 
and bind the amino -terminal region (transit peptide). In order 
to target the bacterial peptide deformylase to chloroplasts, a 
gene segment encoding the plant transit peptide may be fused 
to the coding sequence for the bacterial enZyme. 
The third approach for creating herbicide-tolerant plants 
employs transgenic expression of enZymes that convert the 
herbicide to a form that is not toxic to the plant. Some plants 
have their oWn detoxifying systems for certain herbicides. 
Some bacteria have been found that naturally degrade herbi 
cides. 
The fourth approach for creating herbicide tolerant plants 
draWs from bacterial systems Where knock-out of the formyl 
transferase gene, Which codes for the formyl transferase 
enZyme responsible for the formation of N-formylmethion 
ine, results in the formation of a cell line that While sloW in 
groWth, is no longer susceptible to peptide deformylase 
inhibitors or mutations in the peptide deformylase gene. 
In order to express all or an effective part of the DNA 
sequence encoding a peptide deformylase protein of this 
invention in E. coli and in plants, suitable restriction sites can 
be introduced, ?anking the DNA sequence. This can be 
accomplished by site-directed mutagenesis, using Well 
knoWn procedures (Stanssens et al., Nucleic Acids Research 
1214441-4454 (1989); White et al., Trends in Genet. 51185 
189 (1989)). In order to obtain improved expression in plants, 
the codon usage of the peptide deformylase gene or effective 
peptide deformylase gene part of this invention can be modi 
?ed to form an equivalent, modi?ed or arti?cial gene or gene 
part, or gene parts can be inserted in the chloroplast genome 
and expressed there using a chloroplast-active promoter (e.g., 
McBride et al., Bio/Technology 131362 (1995)). For obtain 
ing enhanced expression in monocot plants such as com, a 
monocot intron also can be added to the chimeric gene, and 
the DNA sequence of the peptide deformylase gene or part 
thereof can be further changed in a translationally neutral 
manner, to modify possibly inhibitory DNA sequences 
present in the gene or gene part by means of site-directed 
intron insertion and/or by introducing changes to the codon 
usage, e.g., adapting the codonusage to that most preferred by 
the speci?c plant (Murray et al., Nucleic Acids Research 
17(2):477-498 (1989)) Without changing signi?cantly the 
encoded amino acid sequence. 
Furthermore, the binding properties of the peptide 
deformylase proteins of the invention can be evaluated, using 
methods knoWn in the art. 
20 
25 
30 
35 
40 
50 
55 
60 
65 
14 
The peptide deformylase gene part or its equivalent, pref 
erably a peptide deformylase chimeric gene, encoding a vari 
ant of the peptide deformylase, can be stably inserted in a 
conventional manner into the nuclear genome of a single 
plant cell, and the transformed plant cell can be used in a 
conventional manner to produce a transformed plant that is 
resistant to a peptide deformylase inhibitor. 
In this regard, a disarmed Ti-plasmid, containing the pep 
tide deformylase gene or part thereof, in Agrobaclerium 
Zumefaciens can be used to transform the plant cell, and 
thereafter, a transformed plant can be regenerated from the 
transformed plant cell using the procedures described. For 
example, preferred Ti-plasmid vectors each contain the pep 
tide deformylase gene or part thereof betWeen the border 
sequences, or at least located to the left of the right border 
sequence, of the T-DNA of the Ti-plasmid. Of course, other 
types of vectors can be used to transform the plant cell, using 
procedures such as direct gene transfer, pollen-mediated 
transformation, plant RNA virus-mediated transformation, 
liposome-mediated transformation, and other methods such 
as the recently described methods for transforming certain 
lines of corn (Fromm et al., Bio/Technology 81833-839 
(1990); Gordon-Kamm et al., The Plant Cell 21603-618 
(1990)) and rice (Shimamoto et al., Nature 3381274-276 
(1989); Datta et al., Bio/Technology 81736-740 (1990)) and 
the recently described method for transforming monocots 
generally (PCT publication W0 92/ 09696). 
The resulting transformed plant can be used in a conven 
tional plant breeding scheme to produce more transformed 
plants With the same characteristics or to introduce the pep 
tide deformylase gene part in other varieties of the same or 
related plant species. Seeds, Which are obtained from the 
transformed plants, contain the peptide deformylase gene 
part as a stable genomic insert. Cells of the transformed plant 
can be cultured in a conventional manner to produce the 
peptide deformylase protein Which can be recovered for use 
in methods of identifying herbicidal compounds. 
The peptide deformylase gene or gene part, preferably the 
truncated peptide deformylase gene, may be inserted in a 
plant cell genome so that the inserted gene is doWnstream 
(i.e., 3') of, and under the control of, a promoter Which can 
direct the expression of the gene part in the plant cell. This is 
preferably accomplished by inserting the peptide deformy 
lase chimeric gene in the plant cell genome particularly in the 
nuclear genome. Preferred promoters include: the strong con 
stitutive 35S promoters (the “35S promoters”) of the cauli 
?oWer mosaic virus (CaMV) of isolates CM 1841 (Gardner et 
al., Nucleic Acids Research 912871-2887 (1981)), CabbB-S 
(Franck et al., Cell 211285-294 (1980)) and CabbB-Jl (Hull 
and HoWell, Virology 861482-493 (1987)); promoters from 
the ubiquitin family (e.g., the maiZe ubiquitin promoter of 
Christensen et al., Plant Mol. Biol. 181675-689 (1992), see 
also Comejo et al., Plant Mol. Biol. 231567-581 (1993)), the 
gos2 promoter (de Pater et al., 1992), the emu promoter (Last 
et al., Theor. Appl. Genet. 811581-588 (1990)), rice actin 
promoters such as the promoter described by Zhang et al., The 
Plant Cell 311155-1165 (1991); and the TR1' promoter and 
the TR2' promoter (the “TR1' promoter” and the “TR2' pro 
moter”, respectively) Which drive the expression of the 1' and 
2' genes, respectively, of the T-DNA (Velten et al., EMBO J. 
312723-2730 (1984)). 
Alternatively, a promoter can be utiliZed Which is not con 
stitutive but rather is speci?c for one or more tissues or organs 
of the plant (e.g., leaves and/or roots) Whereby the inserted 
peptide deformylase gene part is expressed only in cells of the 
speci?c tissue(s) or organ(s). For example, the peptide 
deformylase gene part could be selectively expressed in the 
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leaves of a plant (e.g., corn, cotton) by placing the gene part 
under the control of a light-inducible promoter such as the 
promoter of the ribulose-1,5-bisphosphate carboxylase small 
subunit gene of the plant itself or of another plant such as pea 
as disclosed in US. Pat. No. 5,254,799. Another alternative is 
to use a promoter Whose expression is inducible (e. g., by 
temperature or chemical factors). 
The peptide deformylase gene or part thereof may be 
inserted in the plant genome so that the inserted gene part is 
upstream (i.e., 5') of suitable 3' end transcription regulation 
signals (i.e., transcript formation and polyadenylation sig 
nals). This is preferably accomplished by inserting the pep 
tide deformylase chimeric gene in the plant cell genome. 
Preferred polyadenylation and transcript formation signals 
include those of the octopine synthase gene (Gielen et al., 
EMBO J. 3:835-845 (1984)) and the T-DNA gene 7 (Velten 
and Schell, Nucleic Acids Research 13:6981-6998 (1985)), 
Which act as 3'-untranslated DNA sequences in transformed 
plant cells. 
The peptide deformylase gene or part thereof can option 
ally be inserted in the plant genome as a hybrid gene (U .S. Pat. 
No. 5,254,799; Vaeck et al., J. Econ. Entomol 55: 140 (1962)) 
under the control of the same promoter as a selectable marker 
gene, such as the neo gene (EP 0 242 236) encoding kanamy 
cin resistance, so that the plant expresses a fusion protein. 
Glossary 
The folloWing de?nitions are provided to facilitate under 
standing of certain terms used frequently herein. 
A “host cell” is a cell Which has been transformed or 
transfected, or is capable of transformation or transfection by 
an exogenous polynucleotide sequence. 
“Homologous” or “substantial identity,” When referring to 
nucleic acids as used herein denotes a characteristic of a 
nucleic acid sequence, Wherein a nucleic acid sequence has at 
least about 70 percent sequence identity as compared to a 
reference sequence, typically at least about 85 percent 
sequence identity, and preferably at least about 95 percent 
sequence identity as compared to a reference sequence. The 
percentage of sequence identity is calculated excluding small 
deletions or additions Which total less than 25 percent of the 
reference sequence. “Identity,” as knoWn in the art, is a rela 
tionship betWeen tWo or more polypeptide sequences or tWo 
or more polynucleotide sequences, as determined by compar 
ing the sequences. In the art, “identity” also means the degree 
of sequence relatedness betWeen polypeptide or polynucle 
otide sequences, as the case may be, as determined by the 
match betWeen strings of such sequences. “Identity” and 
“similarity” can be readily calculated by knoWn methods, 
including but not limited to those described in (Computa 
tional Molecular Biology, Lesk, A. M., ed., Oxford Univer 
sity Press, NeW York, 1988; Biocomputing: Informatics and 
Genome Projects, Smith, D. W., ed., Academic Press, NeW 
York, 1993; Computer Analysis of Sequence Data, Part I, 
Grif?n, A. M., and Grif?n, H. G., eds., Humana Press, NeW 
Jersey, 1994; Sequence Analysis in Molecular Biology, von 
Heinje, G., Academic Press, 1987; and Sequence Analysis 
Primer, Gribskov, M. and Devereux, J ., eds., M Stockton 
Press, NeW York, 1991; and Carillo, H., and Lipman, D., 
SIAM J. Applied Math., 48: 1073 (1988). Preferred methods 
to determine identity are designed to give the largest match 
betWeen the sequences tested. Methods to determine identity 
and similarity are codi?ed in publicly available computer 
programs. Preferred computer program methods to determine 
identity and similarity betWeen tWo sequences include, but 
are not limited to, the GCG program package (Devereux, J ., et 
al., Nucleic Acids Research 12(1): 387 (1984)), BLASTP, 
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BLASTN, and FASTA (Atschul, S. F. et al., J. Molec. Biol. 
215: 403-410 (1990). The BLAST X program is publicly 
available from NCBI and other sources (BLAST Manual, 
Altschul, S., et al., NCBI NLM NIH Bethesda, Md. 20894; 
Altschul, S., et al., J. Mol. Biol. 215: 403-410 (1990). As an 
illustration, by a polynucleotide having a nucleotide sequence 
having at least, for example, 95% “identity” to a reference 
nucleotide sequence, it is intended that the nucleotide 
sequence of the polynucleotide is identical to the reference 
sequence except that the polynucleotide sequence may 
include up to ?ve point mutations per each 100 nucleotides of 
the reference nucleotide sequence. In other Words, to obtain a 
polynucleotide having a nucleotide sequence at least 95% 
identical to a reference nucleotide sequence, up to 5% of the 
nucleotides in the reference sequence may be deleted or sub 
stituted With another nucleotide, or a number of nucleotides 
up to 5% of the total nucleotides in the reference sequence 
may be inserted into the reference sequence. These mutations 
of the reference sequence may occur at the 5' or 3' terminal 
positions of the reference nucleotide sequence or anyWhere 
betWeen those terminal positions, interspersed either indi 
vidually among nucleotides in the reference sequence or in 
one or more contiguous groups Within the reference 
sequence. Analogously, by a polypeptide having an amino 
acid sequence having at least, for example, 95% identity to a 
reference amino acid sequence, it is intended that the amino 
acid sequence of the polypeptide is identical to the reference 
sequence except that the polypeptide sequence may include 
up to ?ve amino acid alterations per each 100 amino acids of 
the reference amino acid. In other Words, to obtain a polypep 
tide having an amino acid sequence at least 95% identical to 
a reference amino acid sequence, up to 5% of the amino acid 
residues in the reference sequence may be deleted or substi 
tuted With another amino acid, or a number of amino acids up 
to 5% of the total amino acid residues in the reference 
sequence may be inserted into the reference sequence. These 
alterations of the reference sequence may occur at the amino 
or carboxy terminal positions of the reference amino acid 
sequence or anyWhere betWeen those terminal positions, 
interspersed either individually among residues in the refer 
ence sequence or in one or more contiguous groups Within the 
reference sequence. The reference sequence in the instant 
case may be the sequence of Atdefl, Atdef2, AtDEFl, or 
AtDEF2. 
“Isolated” means altered “by the hand of man” from its 
natural state, i.e., if it occurs in nature, it has been changed or 
removed from its original environment, or both. For example, 
a polynucleotide or a polypeptide naturally present in a living 
organism is not “isolated”, but the same polynucleotide or 
polypeptide separated from the coexisting materials of its 
natural state is “isolated”, as the term is employed herein. 
“Polynucleotide(s)” generally refers to any polyribonucle 
otide or polydeoxribonucleotide, Which may be unmodi?ed 
RNA or DNA or modi?ed RNA or DNA. “Polynucleotide(s)” 
include, Without limitation, single- and double-stranded 
DNA, DNA that is a mixture of single- and double-stranded 
regions or single-, double- and triple-stranded regions, 
single- and double-stranded RNA, and RNA that is mixture of 
single- and double-stranded regions, hybrid molecules com 
prising DNA and RNA that may be single-stranded or, more 
typically, double-stranded, or triple-stranded regions, or a 
mixture of single- and double-stranded regions. In addition, 
“polynucleotide” as used herein refers to triple-stranded 
regions comprising RNA or DNA or both RNA and DNA. 
The strands in such regions may be from the same molecule or 
from different molecules. The regions may include all of one 
or more of the molecules, but more typically involve only a 
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region of some of the molecules. One of the molecules of a 
triple-helical region often is an oligonucleotide. As used 
herein, the term “polynucleotide(s)” also includes DNAs or 
RNAs as described above that contain one or more modi?ed 
bases. Thus, DNAs or RNAs With backbones modi?ed for 
stability or for other reasons are “polynucleotide(s)” as that 
term is intended herein. Moreover, DNAs or RNAs compris 
ing unusual bases, such as inosine, or modi?ed bases, such as 
tritylated bases, to name just tWo examples, are polynucle 
otides as the term is used herein. It Will be appreciated that a 
great variety of modi?cations have been made to DNA and 
RNA that serve many useful purposes knoWn to those of skill 
in the art. The term “polynucleotide(s)” as it is employed 
herein embraces such chemically, enzymatically or metaboli 
cally modi?ed forms of polynucleotides, as Well as the chemi 
cal forms of DNA and RNA characteristic of viruses and cells, 
including, for example, simple and complex cells. “Poly 
nucleotide(s)” also embraces short polynucleotides often 
referred to as oligonucleotide(s). 
“Polypeptide(s)” refers to any peptide or protein compris 
ing tWo or more amino acids joined to each other by peptide 
bonds or modi?ed peptide bonds. “Polypeptide(s)” refers to 
both short chains, commonly referred to as peptides, oli 
gopeptides and oligomers and to longer chains generally 
referred to as proteins. Polypeptides may contain amino acids 
other than the 20 gene encoded amino acids. “Polypeptide(s)” 
include those modi?ed either by natural processes, such as 
processing and other post-translational modi?cations, but 
also by chemical modi?cation techniques. Such modi?ca 
tions are Well described in basic texts and in more detailed 
monographs, as Well as in a voluminous research literature, 
and they are Well knoWn to those of skill in the art. It Will be 
appreciated that the same type of modi?cation may be present 
in the same or varying degree at several sites in a given 
polypeptide. Also, a given polypeptide may contain many 
types of modi?cations. Modi?cations can occur anyWhere in 
a polypeptide, including the peptide backbone, the amino 
acid side-chains, and the amino or carboxyl termini. 
Modi?cations include, for example, acetylation, acylation, 
ADP-ribosylation, amidation, covalent attachment of ?avin, 
covalent attachment of a heme moiety, covalent attachment of 
a nucleotide or nucleotide derivative, covalent attachment of 
a lipid or lipid derivative, covalent attachment of phosphoti 
dylinositol, cross-linking, cyclization, disul?de bond forma 
tion, demethylation, formation of covalent cross-links, for 
mation of cysteine, formation of pyroglutamate, formylation, 
gamma-carboxylation, glycosylation, GPI anchor formation, 
hydroxylation, iodination, methylation, myristoylation, oxi 
dation, proteolytic processing, phosphorylation, prenylation, 
racemization, glycosylation, lipid attachment, sulfation, 
gamma-carboxylation of glutamic acid residues, hydroxyla 
tion and ADP-ribosylation, selenoylation, transfer-RNA 
mediated addition of amino acids to proteins, such as arginy 
lation, and ubiquitination. (See, for example, Proteins-struc 
ture And Molecular Properties, 2nd Ed., T. E. Creighton, W. 
H. Freeman and Company, NeW York (1993) and Wold, F., 
Posttranslational Protein Modi?cations: Perspectives and 
Prospects, pgs. 1-12 in Posttranslational Covalent Modi?ca 
tion of Proteins, B. C. Johnson, Ed., Academic Press, NeW 
York (1983); Seifter et al., Meth. Enzymol. 182:626-646 
(1990) and Rattan et al., Protein Synthesis: Posttranslational 
Modi?cations and Aging, Ann. NY. Acad. Sci. 663:48-62 
(1992)). Polypeptides may be branched or cyclic, With or 
Without branching. Cyclic, branched and branched circular 
polypeptides may result from post-translational natural pro 
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cesses and may be made by entirely synthetic methods, as 
Well. The terms “peptide”, “polypeptide” or “protein” are 
used interchangeably herein. 
“Stringent hybridization conditions” refers to conditions 
Which permit hybridization betWeen polynucleotides. Strin 
gent conditions can be de?ned by salt concentration, the 
concentration of organic solvent (e.g., formamide), tempera 
ture, and other conditions Well knoWn in the art. In particular, 
stringency can be increased by reducing the concentration of 
salt, increasing the concentration of formamide, or raising the 
hybridization temperature. For example, stringent salt con 
centration Will ordinarily be less than about 750 mM NaCl 
and 75 mM trisodium citrate, preferably less than about 500 
mM NaCl and 50 mM tri sodium citrate, and mo st preferably 
less than about 250 mM NaCl and 25 mM trisodium citrate. 
LoW stringency hybridization can be obtained in the absence 
of organic solvent, e. g., formamide, While high stringency 
hybridization can be obtained in the presence of at least about 
35% formamide, and most preferably at least about 50% 
formamide. Stringent temperature conditions Will ordinarily 
include temperatures of at least about 30° C., more preferably 
of at least about 37° C. and most preferably of at least about 
42° C. Varying additional parameters, such as hybridization 
time, the concentration of detergent, e.g., sodium dodecyl 
sulfate (SDS), and the inclusion or exclusion of carrier DNA, 
are Well knoWn to those skilled in the art. Various levels of 
stringency are accomplished by combining these various con 
ditions as needed. The Washing steps Which folloW hybrid 
ization can also vary in stringency. Wash stringency condi 
tions can be de?ned by salt concentration and by temperature. 
As above, Wash stringency can be increased by decreasing 
salt concentration or by increasing temperature. For example, 
stringent salt concentration for the Wash steps Will preferably 
be less than about 30 mM NaCl and 3 mM trisodium citrate, 
and most preferably less than about 15 mM NaCl and 1 .5 mM 
trisodium citrate. Stringent temperature conditions for the 
Wash steps Will ordinarily include temperature of at least 
about 25° C., more preferably of at least about 42° C., and 
most preferably of at least about 68° C. Will occur at 42° C. in 
15 mM NaCl, 1.5 mM trisodium citrate, and 0.1% SDS. 
Additional variations on these conditions Will be readily 
apparent to those skilled in the art. 
“Variant(s)” as the term is used herein, is a polynucleotide 
or polypeptide that differs from a reference polynucleotide or 
polypeptide respectively, but retains essential properties. A 
typical variant of a polynucleotide differs in nucleotide 
sequence from another reference polynucleotide. Changes in 
the nucleotide sequence of the variant may or may not alter 
the amino acid sequence of a polypeptide encoded by the 
reference polynucleotide. Nucleotide changes may result in 
amino acid substitutions, additions, deletions, fusions and 
truncations in the polypeptide encoded by the reference 
sequence, as discussed beloW. A typical variant of a polypep 
tide differs in amino acid sequence from another, reference 
polypeptide. Generally, differences are limited so that the 
sequences of the reference polypeptide and the variant are 
closely similar overall and, in many regions, identical. A 
variant and reference polypeptide may differ in amino acid 
sequence by one or more substitutions, additions, deletions in 
any combination. A substituted or inserted amino acid residue 
may or may not be one encoded by the genetic code. A variant 
of a polynucleotide or polypeptide may be a naturally occur 
ring such as an allelic variant, or it may be a variant that is not 
knoWn to occur naturally. Non-naturally occurring variants of 
polynucleotides and polypeptides may be made by mutagen 
esis techniques, by direct synthesis, and by other recombinant 
methods knoWn to skilled artisans. 
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All references cited in the present application are expressly 
incorporated by reference herein. 
The following examples are provided for illustrative pur 
poses and are not intended to limit the scope of the invention 
as claimed herein. Any variations in the exempli?ed compo 
sitions and methods that occur to the skilled artisan are 
intended to fall within the scope of the present invention. 
EXAMPLE 1 
Identi?cation and Isolation of an ArabidopsisPeptide 
Deformylase Gene (Atdef 1) 
The Arabidopsis Zhaliana genome sequencing project 
recently annotated a gene (AC007591; F9L1.35 @ httpzww 
w.ncbi.nlm.nih.gov;) as a putative peptide deformylase based 
on substantial homology to Chlamydia pneumoniae 
(AE001687) protein. An identi?able chloroplast targeting 
sequence was also identi?ed. The predicted protein sequence 
was analyZed using the ChloroP program (Emanuelsson et 
al., Protein Science 8:978-984 (1999)), which revealed a 
putative transit peptide of 50 amino acids. (See FIGS. 1A and 
1B.) 
Construction of a Peptide Deformylase Clone (Atdefl) 
Experiments were initiated to amplify Arabidopsis 
Zhaliana peptide deformylase complementary DNA (cDNA) 
using Reverse Transcriptase-Polymerase Chain Reaction 
(RT-PCR). 
Isolation of Arabidopsis Zhaliana RNA 
Total RNA was isolated using TRIZolTM reagent from 
GIBCO BRL, following the manufacturer’s protocol. Brie?y, 
the procedure was as follows: 0.5 gm Arabidopsis Zhaliana 
cv. Columbia leaves were homogenized in 5 ml of TRIZolTM 
reagent with a Polytron homo geniZer for 10-15 seconds using 
a power setting of 5. Following a 5 minute room temperature 
incubation, 1.0 ml of chloroform was added. The samples 
were mixed and centrifuged at 12,000><g for 15 minutes at 4° 
C. Following centrifugation, the aqueous phase was removed 
and the RNA precipitated with 2.5 ml of isopropyl alcohol. 
The precipitate was collected by centrifugation at 12,000><g 
for 10 minutes at 4° C. The RNA pellet was washed with 1.0 
ml of 70% ethanol, dried brie?y, and resuspended in DEPC 
treated water. 
First Strand cDNA Synthesis 
First strand cDNA was prepared from RNA isolated from 
Arabidopsis Zhaliana cells using gene speci?c primers RLH 
146 (SEQ ID NO.: 1) and 147 (SEQ ID NO.: 2) having the 
sequence 5' TTG TCG ACA AAA GCC GGT TGG 3' and 5' 
TCA TTG AGG ICC GAG CTT AG 3', respectively. The 
reverse transcription reaction was carried out in a 20 pl reac 
tion volume containing 4 pl of RNA (150 ng/ml), 1.5 pl of 3' 
antisense oligo (likely RLH 147) (10 pM stock diluted to a 
?nal concentration of 0.75 pM), 8.5 pl of water, 1 pl of 20 mM 
each dATP, dGTP, dCTP, dTTP (?nal concentration of 1 
mM), 2 pl of MgCl2 (to ?nal concentration of 5 mM), 2 pl of 
PCR buffer (10><: 200 mM Tris-HCl, pH 8.4, 500 mM KCl) 
used according to the manufacturer’s instructions (Gibco 
BRL® Life TechnologiesTM) and 200 units of MMLV reverse 
transcriptase (Gibco BRL® Life TechnologiesTM) for 30 min 
utes at 42° C. in a RoboCycler® Gradient 40 Temperature 
Cycler (Stratagene®; La Jolla, Calif., USA 92037). This reac 
tion was terminated by incubation at 99° C. for 5 minutes and 
subsequently cooled to 60° C. 
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Polymerase Chain Reaction 
The ?rst strand cDNA was used as a PCR template. Rob 
oCycler® Gradient 40 Temperature Cycler was used with the 
following temperature regime: 
1 cycle 3 minutes 94° C. 
35 cycles 1 minute 94° C., 1 minute 50° C., 1 minute 72° C. 
1 cycle 10 minutes 72° C. 
The reaction product was analyZed by adding an aliquot of 
the reaction mixture to loading dye and loading into wells of 
a 1% TAE gel and subjecting the gel to electrophoresis. (FIG. 
2.) 
Ligation to pCR®2.1 Vector 
The amplicon of the expected siZe, 630 bp, was cloned into 
pCR®2.1 TA-vector (Invitrogen). (See FIG. 2.) The 10 pl 
ligation reaction mixture contained 1-2 pl of PCR product, 1 
pl of 10x ligation buffer, 2 pl of pCR®2.1 vector (25 ng/pl), 
sterile water to a total volume of 10 pl. One microliter of T4 
DNA Ligase (4.0 Weiss units) was added to the reaction 
mixture and the ligation reaction was incubated at 14° C. for 
a 14-16 hours. 
Transformation 
To each vial of One ShotTM INVotF' competent cells (Invit 
rogen) were added 2 pl of 0.5M [3-mercaptoethanol and the 
sample was mixed by stirring gently with a pipette tip. After 
wards, 2 pl of the TA Cloning® reaction (ligation reaction) 
were added into a vial of One ShotTM cells and mixed gently. 
The mixture was incubated on ice for 30 minutes. The cells 
were subjected to heat shock for 30 seconds at 42° C. without 
shaking. The cells were then immediately transferred to ice 
and incubated for 2 minutes. Next, 250 pl of room tempera 
ture SOC medium (formulation per liter: 20 g tryptone, 5 g 
yeast extract, 0.5 g NaCl, 0.95 g MgCl2, and 20 mM glucose) 
were added. The tube was capped tightly and shaken horiZon 
tally at 37° C. for 60 minutes. 
Approximately, 50-100 pl from each transformation were 
spread on a prewarmed LB-agar plate containing the 100 
pg/ml ampicillin and X-Gal, and the inverted plates were 
incubated overnight at 37° C. Approximately 10 white or light 
blue colonies were picked for analysis. 
Sequence Analysis 
Determination of the DNA sequence of the insert con 
?rmed that this plasmid had the expected and desired struc 
ture. Sequence determinations were carried out by the 
dideoxynucleotide chain termination procedure (Sanger et al. 
(1977) Proc. Natl. Acad. Sci. USA 74:8073-8077), with an 
automated ?uorescence-based system (Applied Biosystems, 
Foster City, Calif.). The DNA sequence of the Atdefl insert is 
identical to the deduced [computer generated] cDNA 
sequence of gene AC 0075912 in the Arabidopsisgenome 
sequence. 
EXAMPLE 2 
Expression and Puri?cation of Arabidopsis Zhaliana Peptide 
Deformylase (AtDEF 1) 
Cloning into pLEX 
Restriction Endonuclease Digestion 
The peptide deformylase gene (from Example I) was 
digested with NdeI and XhoI and ligated into pLEX (Invitro 
gen) that had been digested with NdeI and XhoI restriction 









